Whether insulin resistance and hyperinsulin secretion compensation are the result of Rgs5-deficient-induced obesity or whether Rgs5 directly mediates insulin secretion and insulin signaling, as well as the effect of Rgs5 expression on β-cell mass and apoptosis, requires further experimental evidence. Here, RGS5 is linked to obesity due to melanocortin 4 receptor deficiency.